Revolution Medicines, Inc.RVMDNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-897.74M
↓ 244% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-261.22M
Historical baseline
PeriodValueYoY Change
2025$-897.74M-61.0%
2024$-557.44M-59.0%
2023$-350.57M-56.2%
2022$-224.40M-52.5%
2021$-147.18M-47.1%
2020$-100.06M-101.7%
2019$-49.62M-4190.4%
2018$1.21M+104.8%
2017$-25.15M-